Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Non Operating Income: 2009-2025

Historic Non Operating Income for Myriad Genetics (MYGN) over the last 14 years, with Sep 2025 value amounting to -$2.9 million.

  • Myriad Genetics' Non Operating Income fell 141.67% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year decrease of 450.00%. This contributed to the annual value of $1.1 million for FY2024, which is 122.92% up from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Non Operating Income is -$2.9 million, which was down 107.14% from -$1.4 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Non Operating Income high stood at $120.6 million for Q3 2021, and its period low was -$2.9 million during Q1 2021.
  • For the 3-year period, Myriad Genetics' Non Operating Income averaged around -$845,455, with its median value being -$900,000 (2023).
  • As far as peak fluctuations go, Myriad Genetics' Non Operating Income spiked by 3,041.46% in 2021, and later slumped by 2,500.00% in 2023.
  • Quarterly analysis of 5 years shows Myriad Genetics' Non Operating Income stood at $120.6 million in 2021, then tumbled by 99.34% to $800,000 in 2022, then crashed by 237.50% to -$900,000 in 2023, then surged by 133.33% to $300,000 in 2024, then crashed by 141.67% to -$2.9 million in 2025.
  • Its Non Operating Income was -$2.9 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$400,000 in Q1 2025.